Loading...
•
Mar 31, 2023
ICU Medical Q1 2023 Earnings Report
ICU Medical's first quarter results were generally in line with expectations, with revenue increasing compared to the same period last year and adjusted diluted earnings per share decreasing.
Key Takeaways
ICU Medical reported first quarter 2023 revenue of $568.6 million, a gross profit of $192.0 million, and a net loss of $(9.8) million, or $(0.41) per diluted share. Adjusted diluted earnings per share was $1.74, and adjusted EBITDA was $102.0 million.
First quarter revenue was $568.6 million, compared to $543.1 million in the same period last year.
GAAP gross profit for the first quarter was $192.0 million, compared to $168.8 million in the same period last year.
GAAP net loss was $(9.8) million, or $(0.41) per diluted share, compared to $(38.1) million, or $(1.61) per diluted share, for the same period last year.
Adjusted diluted earnings per share was $1.74, compared to $1.82 for the first quarter of 2022.
Revenue by Segment
Forward Guidance
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as ''will,'' ''expect,'' ''believe,'' ''could,'' ''would,'' ''estimate,'' ''continue,'' ''build,'' ''expand'' or the negative thereof or comparable terminology, and may include (without limitation) information regarding the Company's expectations, goals or intentions regarding the future.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...